Plain-English translation of NCT06078735 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After heart ablation procedures for atrial fibrillation, doctors need to close the small puncture wound made in your groin. This trial compares two methods: the LockeT device, which is a new suture-retention system designed to hold pressure on the wound without requiring a healthcare worker to stand beside you for hours, versus the standard approach of manual compression (a nurse or technician pressing on the wound by hand). The goal is to see if the LockeT device works as well as or better than manual compression while letting you get up and move around sooner.
Currently, manual compression requires patients to stay in bed for up to 8 hours after their procedure, which can lead to complications and longer hospital stays. This trial exists to see whether the LockeT device can provide the same safety as manual compression while allowing patients to get back on their feet much sooner.
You likely qualify if…
You likely don't qualify if…
You would undergo your scheduled atrial fibrillation ablation procedure as planned. After the procedure, you would be randomly assigned to have your wound closed either with the LockeT device or with manual compression (standard care). The main difference in your recovery would be how long you need to stay in bed—the LockeT group can typically get up and move around sooner than those receiving manual compression. Researchers will follow up with you to track how well the wound healed and whether you experienced any complications.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States